BioSpace News Archive

52 Presentations by Coalition Members During the Annual Meeting

RenalTech™ predictive diagnostic tool is a first for veterinarians, signaling new potential for personalized health care for pets

Leaders in business intelligence and the cardiovascular space use knowledge exchange and thought leadership in working towards better care and lower costs

Titan Pharmaceuticals, Inc. and Crossroads of Southern Nevada rehabilitation facility announced that Crossroads has healthcare providers who are specially trained in the insertion and removal of Probuphine® implants, and will now offer Probuphine for use in eligible patients with Opioid Use Disorder.

Audentes Therapeutics, Inc. announced that Natalie Holles, President and Chief Operating Officer, will participate in the following investor conferences in October

Hill Holliday has made a key hire for its growing healthcare practice in Linda Bennett, it was announced by Hill Holliday president Chris Wallrapp.

NeuroCycle Therapeutics, Inc. announced that it has been awarded a grant from the Helping to End Addiction Long-termsm Initiative, or the NIH HEAL Initiativesm, to advance development of its novel non-addictive treatment of chronic musculoskeletal pain.

ATCC Genome Portal Provides Access to Reference-quality Genomes, Enabling Increased Confidence in Research [01-October-2019] MANASSAS, Va. , Oct. 1, 2019 /PRNewswire/ -- ATCC launched its new ATCC Genome Portal , a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret

NOCD, a digital behavioral health company that identifies and manages people with obsessive-compulsive disorder (OCD), today announced a Series A fundraising round of $4 million. Led by Chicago Ventures, the round also includes 7Wire Ventures, Meridian Street Capital, and Hyde Park Angels.

Class-action law firm urges CVET investors who have suffered losses of 50K+ to learn their shareholder rights